**>17 years experience in business development, strategy and investment, +8 years in marketing and medical in pharmaceutical industry, with plenty of traceable successful records on both investments and product licensing (in-out) deals.** Good at communication and coordination across different stakeholders to solve tough problems.**Be keen sighted to policy trend of the pharmaceutical industry, value and feasibility of pharmaceutical products which match Chinese market.**Rich practical experiences in designing cooperation modals with biotech companies from both China mainland and overseas.**Highlighted experience in portfolio management, completed in-depth researches on China's marketing opportunity and access feasibility to dozens of therapeutic fields like anti-cancer, CV, CNS, autoimmune diseases, diabetes, respiratory, GI, hepatitis and anti-infection etc. **Proven capability in effectively leading BD, investment, RA, medical and marketing team, in leading Chinese pharmaceutical companies and JV
Chia Tai Pharmaceutical Group Co., Ltd.
-
General Manager, Oversea'S InvestmentChia Tai Pharmaceutical Group Co., Ltd. Feb 2017 - PresentBeijing City, China
-
General Manager Of Policy And Competition Research, A Member Of Investment Decision Making CommitteeChia Tai Pharmaceutical Investment (Beijing) Co., Ltd.(Sino Biopahrmaceutical Ltd.) Aug 2020 - Dec 2021中国 北京市Continuously track the scientific trends of global pharmaceutical industry. Screen and identify those technologies, products and candidate companies best matching COMPANY’s strategic needs, report to the Chairman and investment committee.Policies study:Established and maintained close contact with industry associations, industry experts, government departments and other policy stakeholders, made in-depth study to important government policies and consequences, and put forward response… Show more Continuously track the scientific trends of global pharmaceutical industry. Screen and identify those technologies, products and candidate companies best matching COMPANY’s strategic needs, report to the Chairman and investment committee.Policies study:Established and maintained close contact with industry associations, industry experts, government departments and other policy stakeholders, made in-depth study to important government policies and consequences, and put forward response suggestions to the board.Competition study: Carry out studies on the competitive status and trend of Chinese pharmaceutical market,monitor the R & D and market behavior of major players, and put forward competitive suggestions to the members of the board of directors.Market cap. study:Monitoring change on market capital of main competitive listing companies, identify key affecting factors lead to differences, and put forward suitable improvement suggestions to the board. Show less
-
General Manager, Overseas Investment, A Member Of Investment Decision Making Committee.Chia Tai Pharmaceutical Group(Sino Biopharmaceutical Ltd.) Mar 2017 - Aug 2020中国 北京市**Successfully invested into a leading British High-tech company, as team leader. **Successfully invested into Karolinska Dev., a Swedish company, as a key team member.**Successfully invested into a Japanese biotech company Cosmed as a participant**Be deeply involved into the cooperation models designing, control of negotiation, risks management, DD and decision making process for investing into Ascentage pharm, Akeso, Softhale and Sinovac etc., as key member of decision making… Show more **Successfully invested into a leading British High-tech company, as team leader. **Successfully invested into Karolinska Dev., a Swedish company, as a key team member.**Successfully invested into a Japanese biotech company Cosmed as a participant**Be deeply involved into the cooperation models designing, control of negotiation, risks management, DD and decision making process for investing into Ascentage pharm, Akeso, Softhale and Sinovac etc., as key member of decision making committee.**Led DD process to numbers of overseas and domestic biotech companies for licensing purpose, which include anti-cancer, autoimmune, anti-gout, anti-infection, respiratory, AI discovery, CMC of macromolecule, RNA technology, cell therapy chronic disease management, med-techs etc. Show less
-
Deputy General Manager Of Strategy And R&D ManagementChia Tai Pharmaceutical Investment (Beijing) Co., Ltd.(Sino Biopahrmaceutical Ltd.) May 2013 - Mar 2017中国 北京市**Set up internal strategic communicating mechanism between the HQ and member companies, Define strategic topics based on extensive internal communication and systemic research and organize annual strategic meetings, with all CEOs from member companies involved.**Prospectively discussed and arranged to deal with the substantial price reduction of drugs since 2014. Other topics discussed included digital management, R&D planning in cell therapy, oncolytic virus, RNA, macromolecular… Show more **Set up internal strategic communicating mechanism between the HQ and member companies, Define strategic topics based on extensive internal communication and systemic research and organize annual strategic meetings, with all CEOs from member companies involved.**Prospectively discussed and arranged to deal with the substantial price reduction of drugs since 2014. Other topics discussed included digital management, R&D planning in cell therapy, oncolytic virus, RNA, macromolecular innovative drugs and other directions. **Tracking global technical scientific trend, identify R&D conflicting problems and communicate among subsidiary companies aimed to solve problems. **Led numbers partnership (AI discovery, manufacturing related teches, chronic disease management etc.) projects aimed to improve the subsidiary company’s capability on R&D, manufacturing and on-line sales etc.**Provide tech-by-doing help to some subsidiary companies to improve their BD capabilities and negotiation. Show less
-
Director Of Bd, Ra And Clinical TrialsBeijing Hanmi Pharmaceutical Co.Ltd. May 2005 - May 2013Beijing City, ChinaSuccessfully completed 4 in-license, 3 out-license deals as team leader. Portfolio Management: Effectively organized the screening and evaluation of Chinese market opportunities for Korean headquarters marketed and pipeline products(>500), Put more than 20 important products with unique unmet opportunities into development in China(Respiratory TA etc.). Re-designed the communication system with Korean headquarter and other departments related to business development, registration and… Show more Successfully completed 4 in-license, 3 out-license deals as team leader. Portfolio Management: Effectively organized the screening and evaluation of Chinese market opportunities for Korean headquarters marketed and pipeline products(>500), Put more than 20 important products with unique unmet opportunities into development in China(Respiratory TA etc.). Re-designed the communication system with Korean headquarter and other departments related to business development, registration and clinical studies and significantly improved the communication efficacy. Regulatory Affairs: Pushed and led to more than 20 successful new approvals, and completion of a lot of BE and clinical trial projects as team leader. Successfully led the application and identification process of high-tech enterprises and got approved Show less
-
Senior Manager, Medical Department, E-Marketing DepartmentLivzon Pharmaceutical Co., Ltd. Apr 2001 - May 2005Beijing & Zhuhai City, ChinaPortfolio management: Led the dynamic eveluation to all pipeline products on market feasibility as manager of mrdical department.Support to BD: Led the in-depth evaluation and medical support to in-licensing products. Established a solid relationship with many KOLs and associations, and effectively had KOLs involved into the company's R&D process.Successfully organized all related resources, built up and managed four websites, managed the CRM issues including telephone services… Show more Portfolio management: Led the dynamic eveluation to all pipeline products on market feasibility as manager of mrdical department.Support to BD: Led the in-depth evaluation and medical support to in-licensing products. Established a solid relationship with many KOLs and associations, and effectively had KOLs involved into the company's R&D process.Successfully organized all related resources, built up and managed four websites, managed the CRM issues including telephone services and a periodical journal GI-frontier, 18 issues published. Show less
-
Senior ManagerMedonline May 2000 - Mar 2001Beijing City, ChinaDesigned and set up a medical information website for medical professionals.Led public relationship affairs.The website company successfully obtained a US $1.5 million investment from Morningside.
-
Senior Manager Of Clinical StudyPharm Pacific Pty. Ltd. Feb 1997 - Dec 1999Beijing City, ChinaBe trainned with ICH GCPs and SOPs.Planning, monitoring and managing of clinical trial projects for both registration and promotion purposes.Developing and maintaining of government and KOLs relationship.
-
Director Of Hepatitis DepartmentThe General Hospital Of Petro- North China Sep 1994 - Feb 1997Renqiu City, ChinaBeen the only 29 years-old department director in the hospital’s history.Led daily clinical diagnosis and treatment issues as department director.Had a successful experience of designing and managing a large scale clinical and animal study of traditional Chinese medicine on liver fibrosis as Principle Investigator
-
Resident DoctorThe General Hospital Of Petro North China Sep 1988 - Aug 1994Renqiu City, Hebei ProvinceCompleted clinical trainning courses as a resident. Daily diagnosis and treatment of patients.Got many awards issued by the hospital and the healthcare department of the oilfield.
Larry Liu Education Details
-
Beijing UniversityEmba Courses Training Program -
Chende Medical UniversityMedical Science
Frequently Asked Questions about Larry Liu
What company does Larry Liu work for?
Larry Liu works for Chia Tai Pharmaceutical Group Co., Ltd.
What is Larry Liu's role at the current company?
Larry Liu's current role is General Manager, Policy&Competition Research, A member of Investment Decision Making Committee, Chia Tai Pharmaceutical Investment(Beijing)Co. Ltd.(Sino Biopharmaceutical Ltd.).
What schools did Larry Liu attend?
Larry Liu attended Beijing University, Chende Medical University.
Not the Larry Liu you were looking for?
-
1gmail.com
-
2hotmail.com, lenovo.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial